Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

gemcitabine-DNA-encapsulated EPL-modified co-polymer nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

methylated polyethylene glycol-b-poly lactic-glycolic acid

mPEG-PLGA
Type Polymer
Formula
Role core
2

(4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-1,2-dihydropyrimidin-2-one)

2',2'-difluoro-2'-deoxycytidine 2',2'-difluorodeoxycytidine gemcitabine gemzar dFdC GEM Gem
Type Single Compound
Formula C9H11F2N3O4
Role loaded material
3

ε-polylysine

EPL
Type Biomolecule
Formula
Role layer
4

deoxyribonucleic acid

DNA
Type Biomolecule
Formula
Role layer

Properties

General physical and chemical properties

Property Value Source

Full content is available to subscribers only

To view content please choose from the following:

Applications

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • (4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-1,2-dihydropyrimidin-2-one)
  • methylated polyethylene glycol-b-poly lactic-glycolic acid
  1. 0Hlj5huOCJizkbX9xk
  2. wZbNi
  3. X4sjNVqNZh
Product

gemcitabine-DNA-encapsulated EPL-modified co-polymer nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial